Usana Health Sciences Inc (NYSE:USNA) has reported an insider sale according to a recent SEC filing. Chief Legal Officer Joshua Foukas sold 4,847 shares of the company on February 29, 2024. The company's insider transaction history shows a total of 20 insider sells and no insider buys.